Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00424606
Status:
COMPLETED
Last Update Posted:
2015-05-20
First Post:
2007-01-18
Brief Title:
Epirubicin and Docetaxel Combination ET or Epirubicin Followed by Docetaxel ET for Node Negative N0 High Risk Breast Cancer Patients
Sponsor:
Hellenic Oncology Research Group
Organization:
Hellenic Oncology Research Group
Organization Data
Organization:
Hellenic Oncology Research Group
Class:
OTHER
Study ID:
CT0104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hellenic Oncology Research Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University Hospital of Crete | OTHER |